| ［1］ |
Napolitano M, Balato N, Ayala F, et al. Psoriasis in elderly and non⁃elderly population: clinical and molecular features［J］. G Ital Dermatol Venereol, 2016,151（6）:587⁃595.<br />
|
| ［2］ |
Cybulski M, Krajewska⁃Kulak E. Skin diseases among elderly inhabitants of Bialystok, Poland［J］. Clin Interv Aging, 2015,10:1937⁃1943. doi: 10.2147/CIA.S95248.<br />
|
| ［3］ |
Mponda K, Masenga J. Skin diseases among elderly patients attending skin clinic at the Regional Dermatology Training Centre, Northern Tanzania: a cross⁃sectional study［J］. BMC Res Notes, 2016,9:119. doi: 10.1186/s13104⁃016⁃1933⁃6.<br />
|
| ［4］ |
Kwon HH, Kwon IH, Youn JI. Clinical study of psoriasis occurring over the age of 60 years: is elderly⁃onset psoriasis a distinct subtype?［J］. Int J Dermatol, 2012,51（1）:53⁃58. doi: 10.1111/j. 1365⁃4632.2011.04979.x.<br />
|
| ［5］ |
Phan C, Sigal ML, Estève E, et al. Psoriasis in the elderly: epidemiological and clinical aspects, and evaluation of patients with very late onset psoriasis［J］. J Eur Acad Dermatol Venereol, 2016,30（1）:78⁃82. doi: 10.1111/jdv.12850.<br />
|
| ［6］ |
Potts GA, Hurley MY. Psoriasis in the geriatric population［J］. Clin Geriatr Med, 2013,29（2）:373⁃395. doi: 10.1016/j.cger.2013. 01.004.<br />
|
| ［7］ |
Grozdev IS, Van Voorhees AS, Gottlieb AB, et al. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation［J］. J Am Acad Dermatol, 2011,65（3）:537⁃545. doi: 10.1016/j.jaad.2010.05.014.<br />
|
| ［8］ |
Chiricozzi A, Pavlidis A, Dattola A, et al. Efficacy and safety of infliximab in psoriatic patients over the age of 65［J］. Expert Opin Drug Saf, 2016,15（11）:1459⁃1462. doi: 10.1080/14740338.2016. 1226279.<br />
|
| ［9］ |
Trettel A, Spehr C, Körber A, et al. The impact of age on psoriasis health care in Germany［J］. J Eur Acad Dermatol Venereol, 2017,31（5）:870⁃875. doi: 10.1111/jdv.14115.<br />
|
| ［10］ |
Karreman MC, Weel AE, van der Ven M, et al. Prevalence of psoriatic arthritis in primary care patients with psoriasis［J］. Arthritis Rheumatol, 2016,68（4）:924⁃931. doi: 10.1002/art.39530.<br />
|
| ［11］ |
Shin D, Kim HJ, Kim DS, et al. Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross⁃sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires［J］. Rheumatol Int, 2016,36（2）:207⁃212. doi: 10.1007/s00296⁃015⁃3365⁃3.<br />
|
| ［12］ |
Kamel JG, Yamauchi PS. Managing mild⁃to⁃moderate psoriasis in elderly patients: role of topical treatments［J］. Drugs Aging, 2017,34（8）:583⁃588. doi: 10.1007/s40266⁃017⁃0480⁃8.<br />
|
| ［13］ |
Murdan S. Nail disorders in older people, and aspects of their pharmaceutical treatment［J］. Int J Pharm, 2016,512（2）:405⁃411. doi: 10.1016/j.ijpharm.2016.05.022.<br />
|
| ［14］ |
Klaassen KM, van de Kerkhof PC, Pasch MC. Nail psoriasis: a questionnaire⁃based survey［J］. Br J Dermatol, 2013,169（2）:314⁃319. doi: 10.1111/bjd.12354.<br />
|
| ［15］ |
Chiu HY, Hsieh CF, Chiang YT, et al. Concomitant sleep disorders significantly increase the risk of cardiovascular disease in patients with psoriasis［J］. PLoS One, 2016,11（1）:e0146462. doi: 10.1371/journal.pone.0146462.<br />
|
| ［16］ |
Lebwohl MG, Kavanaugh A, Armstrong AW, et al. US perspectives in the management of psoriasis and psoriatic arthritis: patient and physician results from the population⁃based multinational assess⁃ment of psoriasis and psoriatic arthritis （MAPP） survey［J］. Am J Clin Dermatol, 2016,17（1）:87⁃97. doi: 10.1007/s40257⁃015⁃0169⁃x.<br />
|
| ［17］ |
Koku AAE, Saraçoglu ZN, Metintaş S, et al. Age and gender differences in Framingham risk score and metabolic syndrome in psoriasis patients: a cross⁃sectional study in the Turkish population［J］. Anatol J Cardiol, 2017,17（1）:66⁃72. doi: 10.14744/ AnatolJCardiol.2016.6679.<br />
|
| ［18］ |
Weinberg JM. Psoriasis for seniors［J］. Cutis, 2016,97（2）:83.<br />
|
| ［19］ |
Torsekar R, Gautam MM. Topical therapies in psoriasis［J］. Indian Dermatol Online J, 2017,8（4）:235⁃245. doi: 10.4103/2229⁃5178.209622.<br />
|
| ［20］ |
Proksch E. The role of emollients in the management of diseases with chronic dry skin［J］. Skin Pharmacol Physiol, 2008,21（2）:75⁃80. doi: 10.1159/000112957.<br />
|
| ［21］ |
Balato N, Patruno C, Napolitano M, et al. Managing moderate⁃to⁃severe psoriasis in the elderly［J］. Drugs Aging, 2014,31（4）:233⁃238. doi: 10.1007/s40266⁃014⁃0156⁃6.<br />
|
| ［22］ |
Armstrong AW, Aldredge L, Yamauchi PS. Managing patients with psoriasis in the busy clinic: practical tips for health care practitioners［J］. J Cutan Med Surg, 2016,20（3）:196⁃206. doi: 10.1177/1203475415623508.<br />
|
| ［23］ |
Medina C, Carretero G, Ferrandiz C, et al. Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national Biobadaderm registry［J］. J Eur Acad Dermatol Venereol, 2015,29（5）:858⁃864. doi: 10.1111/jdv.12688.<br />
|
| ［24］ |
Momose M, Asahina A, Hayashi M, et al. Biologic treatments for elderly patients with psoriasis［J］. J Dermatol, 2017,44（9）:1020⁃1023. doi: 10.1111/1346⁃8138.13853.<br />
|
| ［25］ |
Megna M, Napolitano M, Balato N, et al. Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2⁃year period［J］. Clin Exp Dermatol, 2016,41（5）:564⁃566. doi: 10.1111/ced.12850.<br />
|
| ［26］ |
郝阳阳, 张梁宇, 陈杨. 高压氧治疗皮肤病的研究进展［J］. 中华皮肤科杂志, 2016,49（9）:672⁃675. doi: 10.3760/cma.j.issn. 0412⁃4030.2016.09.023.<br />
|
| ［27］ |
Butler G, Michaels JC, Al⁃Waili N, et al. Therapeutic effect ofhyperbaric oxygen in psoriasis vulgaris: two case reports and areview of the literature［J］. J Med Case Rep, 2009,3:7023. doi:10. 4076/1752⁃1947⁃3⁃7023.<br />
|
| ［28］ |
Izumi R, Negi O, Suzuki T, et al. Efficacy of an emollient containing diethylene glycol/dilinoleic acid copolymer for the treat⁃ment of dry skin and pruritus in patients with senile xerosis［J］. J Cosmet Dermatol, 2017,16（4）:e37⁃e41. doi: 10.1111/jocd. 12332.<br />
|
| ［29］ |
Nelson PA, Chew⁃Graham CA, Griffiths CE, et al. Recognition of need in health care consultations: a qualitative study of people with psoriasis［J］. Br J Dermatol, 2013,168（2）:354⁃361. doi: 10.1111/j.1365⁃2133.2012.11217.x.<br />
|
| ［30］ |
Blome C, Gosau R, Radtke MA, et al. Patient⁃relevant treatment goals in psoriasis［J］. Arch Dermatol Res, 2016,308（2）:69⁃78. doi: 10.1007/s00403⁃015⁃1613⁃8.<br />
|
| ［31］ |
Petraškiene R, Valiukeviciene S, Macijauskiene J. Associations of the quality of life and psychoemotional state with sociodemo⁃graphic factors in patients with psoriasis［J］. Medicina （Kaunas）, 2016,52（4）:238⁃243. doi: 10.1016/j.medici.2016.07.001.<br />
|
